NCT05638347View on ClinicalTrials.gov

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions

Inflammatory Bowel Disease

Interventions

DRUG

HRS-7085 tablets

Single oral administration

DRUG

Placebo tablet

Single oral administration

Trial Locations (1)

6009

Linear Clinical Research, Nedlands

All Listed Sponsors

lead

Atridia Pty Ltd.

INDUSTRY